Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Planned sale Chief Medical Officer sold 2,932 shares at $27.09 ($79,428)
  2. 4 Planned sale Chief Commercial Officer sold 2,932 shares at $27.09 ($79,428)
  3. 4 Planned sale Chief Financial Officer sold 2,932 shares at $27.09 ($79,428)
  4. 4 Planned sale Director sold 200 shares at $43.84 ($8,768)
  5. 4 Planned sale Chief Medical Officer sold 2,454 shares at $43.78 ($107,436)
  6. 4 Planned sale Chief Medical Officer sold 200 shares at $43.81 ($8,762)
  7. 4 Planned sale Chief Medical Officer sold 3,302 shares at $43.92 ($145,024)
  8. 4 Planned sale Director sold 200 shares at $41.00 ($8,200)
  9. 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
  10. 4 Planned sale Chief Financial Officer sold 3,651 shares at $36.77 ($134,247)
  11. 4 Open-market sale Principal Accounting Officer sold 8,546 shares at $36.87 ($315,091)
  12. 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
  13. 4 Option exercise Director acquired 2,302 shares (option exercise)
  14. 4 Option exercise Director acquired 2,302 shares (option exercise)
  15. 4 Planned sale Chief Executive Officer sold 11,085 shares at $36.67 ($406,487)
  16. 4 Planned sale Director sold 1,400 shares at $40.00 ($56,000)
  17. 4 Planned sale Chief Medical Officer sold 11,914 shares at an average $37.99 ($452,601)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Planned sale Chief Medical Officer sold 4,091 shares at $34.17 ($139,789)

Page 3 of 38 · 758 filings